Sponsored Content
Canadian Valeant Buys Assets of Gerot Lannach
The Austrian drugmaker Gerot Lannach sells its acetylsalicylic acid business in Russia. The sale price amounts to $ 185m.
Canadian Valeant Buys Assets of Gerot Lannach / Picture: © Vindobona.org
Canada's Valeant Pharmaceuticals International Inc said it will buy some assets of Austrian pharmaceutical company Gerot Lannach, to boost its presence in Central and Eastern Europe. These assets of the company, which makes generic branded drugs, generated revenue of about $ 55m in 2011.
Under the deal, Valeant will acquire the assets for less than three times sales, with up to…
or Log In
Fast News Search